Kamil R Kranc
@kamilkranc
Professor of Haemato-Oncology & Director of Centre for In Vivo Modelling, The Institute of Cancer Research, London, UK
ID: 378892879
https://www.icr.ac.uk/our-research/researchers-and-groups/professor-kamil-kranc 24-09-2011 00:38:41
90 Tweet
429 Takipçi
470 Takip Edilen
🛸Only 3 days left if you want to give a short talk at our inaugural Barts RNA Cancer symposium on 15th June in London at Barts Cancer Institute (Queen Mary). Great lineup of world-renown speakers! Please RT and register here👇👇👇👇
Thank you all for registering to attend the Barts RNA Cancer symposium. We had huge interest and the event has now been oversubscribed and therefore the registration is now closed. We will be soon communicating more details on the finalised programme! Stay tuned! Barts Cancer Institute (Queen Mary)
Check out our Nature Cell Biology N&Vs discussing the latest findings by Dou et al on the identification of a novel non-coding m6A reader (RBFOX2), with potential therapeutic implications in leukemia!! 👇🏻👇🏻🔥🔥 nature.com/articles/s4155…
Very proud to have this new collaborative work published in Cell Stem Cell with Bertie Gottgens Donal O'Carroll. We reveal in situ real-time haematopoietic stem and progenitor cell behaviour linked to gene expression patterns, thus unveiling hierarchal dynamics. The ICR Barts Cancer Institute (Queen Mary)
Very proud of Dr Jozef Durko, who has just passed his PhD viva Barts Cancer Institute (Queen Mary). Many thanks to Keeshan Lab and Rhys Morgan for examining! Best of luck with your move to Iannis Aifantis lab in New York. Jozef is a great young scientist and will be missed in London!
Really enjoyed #EHAReCon2024 conference in Bulgaria with lots of amazing science. Well done to Hannah Lawson for a great talk about the impact of m6A mRNA readers on AML and normal haematopoiesis! European Hematology Association
📰NEWS: Targeting the way that cells sense and adapt to oxygen could offer a new way to treat acute myeloid leukaemia. ICR scientists led by Kamil R Kranc have discovered that existing drugs could be used to treat the aggressive form of #leukaemia. icr.ac.uk/news-archive/s…
🩸JUST 1 DAY TO GO! As we spread awareness of #AcuteMyeloidLeukemia (AML), over the last few days we have been highlighting AML group leaders College of BLS. #KnowAML! Today Prof Richard Darley. Richard co-leads the Cardiff AML Target Discovery and Translation Research Group.
As always, me, Hannah Lawson and others in my Team The ICR were delighted to collaborate with Paolo Gallipoli and Vilma Dembitz, this time on their study discovering SCD as a potential therapeutic target in AML. Congrats Paolo and the Team!